Table of Contents
<< Previous Issue | Oct 2005 (Vol: 2005, Issue: 64) | Next Issue >> |
- Section: Business Commentaries
-
Where Does Innovation Prosper?
- Section: Deal Trackers
-
Increlex (mecasermin)
- Section: Features
-
GSK Keeps an Eye on Vaccines Business with Potential ID Biomedical Acquisition
-
EpiCept Merges with Maxim to Go Public
-
When and How to Find the Right Partner
-
Therapy Focus: Schizophrenia
- Section: General
-
Novartis Backs Alnylam and RNAi
-
ALK-Abello AS
- Section: Licensing
-
Vical Grants More Options to Merck & Co. for Cancer Targets
-
NexMed Signs Global Licensing Deal with Novartis
- Section: Mergers & Acquisitions
-
Inyx Increases Capabilities in the Inhaled Drug Market
-
Covance Acquires Clinical Services Facility from West Pharmaceutical
- Section: Research & Development
-
Cyto Pulse Collaborates with US Army
-
Astex Continues to Sign with Big Pharma